Chatterjee Archana, Bagchi Debasis, Yasmin Taharat, Stohs Sidney J
Department of Pediatrics, Division of Pediatric Infectious Diseases, Creighton University Medical Center, Omaha, NE 68131, USA.
Mol Cell Biochem. 2005 Feb;270(1-2):125-30. doi: 10.1007/s11010-005-5277-0.
Increasing resistance to currently used antimicrobials has resulted in the evaluation of other agents that have antimicrobial activity against Helicobacter pylori. H. pylori American Type Culture Collection (ATCC) strain 49503 (a toxin-producing strain known to be associated with gastric cancer) was grown, a cell suspension prepared in 2 mL PBS and diluted 10-fold. One hundred microL of this cell suspension was added to vitamin C 0.5%, vitamin E 0.5%, garcinol 100 microg/mL, Protykin (containing 50% trans-resveratrol) 100 microg/mL and garcinol + Protykin 100 microg/mL in Lennox broth, and incubated for 16 h under microaerophilic conditions. Three replicates of 10 microL from each 10(-7) dilution tube were plated, colonies were counted after 16 h, and growth of H. pylori was confirmed by the CLO test. These colony counts were compared to control cultures without the addition of any antioxidants. The experiments were then repeated with the addition of 15 microg/mL of clarithromycin to experimental and control samples. Enhanced killing of H. pylori by 37.6% was noted when vitamin C was added, which increased to 66% when clarithromycin was added, compared to controls (p < 0.05). With garcinol and Protykin alone there was 91.4 and 87% killing of H. pylori, respectively, while a combination of garcinol + Protykin resulted in 90.8% killing compared to controls (p < 0.05). When clarithromycin was added, there was 76.3% increased killing with garcinol alone, 55.3% with Protykin alone, and 73.7% with garcinol + Protykin compared to controls (containing clarithromycin) (p < 0.05). Vitamin E had no effect on H. pylori growth compared to controls. We conclude from this study that some antioxidants such as vitamin C, garcinol and Protykin, but not vitamin E, may have potential as antimicrobial agents against H. pylori.
目前使用的抗菌药物耐药性不断增加,促使人们对其他具有抗幽门螺杆菌活性的药物进行评估。培养幽门螺杆菌美国模式培养物集存库(ATCC)菌株49503(一种已知与胃癌相关的产毒素菌株),制备细胞悬液,用2 mL磷酸盐缓冲液(PBS)配制并稀释10倍。将100 μL这种细胞悬液加入含有0.5%维生素C、0.5%维生素E、100 μg/mL藤黄酚、100 μg/mL原花青素(含50%反式白藜芦醇)以及100 μg/mL藤黄酚+原花青素的Lennox肉汤中,在微需氧条件下孵育16小时。从每个10⁻⁷稀释管中取10 μL进行三个重复接种,16小时后计数菌落,并用CLO试验确认幽门螺杆菌的生长情况。将这些菌落计数与未添加任何抗氧化剂的对照培养物进行比较。然后在实验样品和对照样品中添加15 μg/mL克拉霉素,重复上述实验。与对照相比,添加维生素C时幽门螺杆菌的杀灭率提高了37.6%,添加克拉霉素后提高到66%(p<0.05)。单独使用藤黄酚和原花青素时,幽门螺杆菌的杀灭率分别为91.4%和87%,而藤黄酚+原花青素联合使用时,与对照相比杀灭率为90.8%(p<0.05)。添加克拉霉素后,与对照(含克拉霉素)相比,单独使用藤黄酚时杀灭率提高了76.3%,单独使用原花青素时提高了55.3%,藤黄酚+原花青素联合使用时提高了73.7%(p<0.05)。与对照相比,维生素E对幽门螺杆菌生长没有影响。我们从这项研究得出结论,一些抗氧化剂,如维生素C、藤黄酚和原花青素,但不包括维生素E,可能具有作为抗幽门螺杆菌抗菌剂的潜力。